Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$5.17 - $8.5 $5,687 - $9,350
1,100 Added 0.77%
144,800 $787,000
Q1 2024

May 07, 2024

BUY
$5.1 - $7.78 $272,340 - $415,452
53,400 Added 59.14%
143,700 $1.06 Million
Q4 2023

Feb 14, 2024

BUY
$4.15 - $7.2 $267,260 - $463,680
64,400 Added 248.65%
90,300 $476,000
Q3 2023

Nov 14, 2023

SELL
$6.2 - $9.34 $513,980 - $774,286
-82,900 Reduced 76.19%
25,900 $181,000
Q2 2023

Aug 11, 2023

SELL
$8.76 - $11.92 $83,220 - $113,240
-9,500 Reduced 8.03%
108,800 $1 Million
Q1 2023

May 16, 2023

SELL
$10.44 - $12.49 $91,872 - $109,912
-8,800 Reduced 6.92%
118,300 $1.31 Million
Q4 2022

Feb 14, 2023

BUY
$8.01 - $11.35 $901,125 - $1.28 Million
112,500 Added 770.55%
127,100 $1.35 Million
Q3 2022

Nov 14, 2022

BUY
$6.25 - $8.94 $91,250 - $130,524
14,600 New
14,600 $120,000
Q1 2022

May 16, 2022

SELL
$5.73 - $7.81 $234,930 - $320,210
-41,000 Reduced 58.16%
29,500 $214,000
Q4 2021

Feb 14, 2022

SELL
$5.3 - $6.3 $40,810 - $48,510
-7,700 Reduced 9.85%
70,500 $422,000
Q3 2021

Nov 15, 2021

BUY
$5.52 - $6.97 $316,848 - $400,078
57,400 Added 275.96%
78,200 $499,000
Q2 2021

Aug 11, 2021

SELL
$5.88 - $9.54 $78,204 - $126,881
-13,300 Reduced 39.0%
20,800 $147,000
Q1 2021

May 17, 2021

BUY
$5.12 - $10.6 $113,664 - $235,320
22,200 Added 186.55%
34,100 $286,000
Q1 2020

May 15, 2020

SELL
$1.72 - $4.47 $4,128 - $10,728
-2,400 Reduced 16.78%
11,900 $27,000
Q4 2019

Feb 14, 2020

SELL
$4.3 - $5.38 $72,240 - $90,384
-16,800 Reduced 54.02%
14,300 $63,000
Q3 2018

Nov 14, 2018

SELL
$2.66 - $3.49 $798 - $1,047
-300 Reduced 0.96%
31,100 $96,000
Q4 2017

Feb 14, 2018

BUY
$2.65 - $3.39 $5,830 - $7,458
2,200 Added 7.53%
31,400 $90,000
Q3 2017

Nov 14, 2017

BUY
$2.59 - $3.1 $75,628 - $90,520
29,200
29,200 $87,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $88.6M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.